Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pro-ocular for Dry Eye Disease
NCT04884217Phase 2Unknown
- Sponsor
- Pharmadax Inc.
- Start
- May 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of progesterone in dry eye disease (DED), sponsored by Pharmadax Inc.. Status: unknown.
02
Drugs
progesterone
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04884217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04884217.